Distribution of a third vaccine to combat COVID-19 has begun across the country, following federal approval last week. The federal Food and Drug Administration on February 27 granted emergency use authorization for a single-shot COVID-19 vaccine from Janssen, a division of Johnson & Johnson.
The new vaccine, authorized for people age 18 and older, will expand the total supply and accelerate progress toward a return to normal life. "To get control of the COVID-19 pandemic, stay ahead of worrisome viral mutations, and protect the American public, we must vaccinate as many Americans as we can as quickly as possible," National Institutes of Allergy and Infectious Diseases director Dr.